INCR
BEARISHAt a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
AI-powered fundamental assessment
Key Strengths
Key Risks
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Trades at a massive discount to book value, but earnings quality is too poor to justify a value play.
- P/B ratio of 0.10 is exceptionally low
- No Graham Number available
- Negative earnings make P/E metrics irrelevant
Growth metrics are insufficient to reverse the current downward trajectory.
- Marginal revenue growth (3.4%)
- EPS growth is crashing (-72.7% Q/Q)
- Technical trend is 0/100 (Bearish)
Historical performance is overwhelmingly negative across 1, 3, and 5-year horizons.
- Consistent multi-year price collapse
- Poor earnings track record
Balance sheet liquidity is the only saving grace, but operational health is failing.
- Low Debt/Equity
- Healthy Current Ratio
- Piotroski F-Score 2/9 indicates fundamental weakness
Company is not returning capital to shareholders.
- No dividend payments
- 0/100 dividend strength
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for INCR and closest competitors.
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
INCR
InterCure Ltd.
Primary
|
-91.7% | -67.4% | -37.5% | -52.3% | -4.7% | +0.4% |
|
APLM
Apollomics, Inc.
Peer
|
-98.0% | -98.1% | +148.8% | +191.4% | -0.5% | -0.8% |
|
ARAY
Accuray Incorporated
Peer
|
-93.2% | -87.0% | -78.7% | -76.4% | -27.4% | -24.4% |
|
BDMD
Baird Medical Investment Holdings Limited
Peer
|
-89.3% | -90.0% | -87.4% | -49.5% | -26.9% | -10.4% |
|
ATRA
Atara Biotherapeutics, Inc.
Peer
|
-98.9% | -95.6% | -24.7% | -54.9% | -70.3% | +15.0% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability
Profit margins and return metrics
Growth
Revenue and earnings growth rates
Financial Health
Balance sheet strength and liquidity metrics
Financial Statement Flow
Interactive flow visualization showing how money moves through the company Q4 2024
Quarterly Earnings History
EPS performance vs analyst estimates
Healthcare Sector Comparison
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
INCR
InterCure Ltd.
|
BEARISH | $41.72M | - | -16.7% | -29.2% | $0.76 | |
|
APLM
Apollomics, Inc.
|
BEARISH | $42.65M | - | -380.1% | -% | $19.9 | Compare |
|
ARAY
Accuray Incorporated
|
BEARISH | $44.0M | - | -70.3% | -8.2% | $0.37 | Compare |
|
BDMD
Baird Medical Investment...
|
BEARISH | $37.83M | - | -8.0% | -10.0% | $1.03 | Compare |
|
ATRA
Atara Biotherapeutics, Inc.
|
BEARISH | $37.64M | 1.83 | -% | 15.4% | $5.22 | Compare |
Past News Coverage
Recent headlines mentioning INCR from our newsroom.